Immediate Impact
65 standout
Citing Papers
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd)
2025 Standout
Works of Atsuko Kitano being referenced
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
2017 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Atsuko Kitano | 449 | 7 | 5 | 198 | 169 | 18 | 562 | |
| Frederike Bensch | 363 | 352 | 132 | 24 | 570 | |||
| Christy Osgood | 341 | 4 | 122 | 156 | 19 | 501 | ||
| Sunil Verma | 334 | 9 | 2 | 147 | 152 | 25 | 648 | |
| Véronique Debien | 376 | 1 | 114 | 149 | 29 | 510 | ||
| Samuel L. Rice | 185 | 3 | 1 | 237 | 200 | 24 | 623 | |
| Normando Iznaga-Escobar | 310 | 1 | 3 | 291 | 190 | 25 | 599 | |
| Preeti Trisal | 400 | 1 | 240 | 95 | 11 | 536 | ||
| Koh Furugaki | 399 | 1 | 141 | 277 | 20 | 631 | ||
| Peter Sawan | 313 | 1 | 88 | 277 | 19 | 471 | ||
| Christopher Parker | 156 | 1 | 205 | 277 | 28 | 628 |
All Works
Login with ORCID to disown or claim papers
Loading papers...